Cellebrite DI (CLBT) News Today → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free CLBT Stock Alerts $11.55 +0.02 (+0.17%) (As of 08:50 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 8:26 PM | marketbeat.comIGP Investments G.P.L.P LP Purchases New Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)IGP Investments G.P.L.P LP acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 21,087,692 shares of the company'sMay 17 at 5:20 AM | americanbankingnews.comCellebrite DI Ltd. (NASDAQ:CLBT) Sees Large Decrease in Short InterestMay 16, 2024 | globenewswire.comCellebrite Announces Participation in Upcoming Investor ConferencesMay 16, 2024 | americanbankingnews.comCellebrite DI (CLBT) Set to Announce Earnings on ThursdayMay 8, 2024 | finance.yahoo.comAn Intrinsic Calculation For Cellebrite DI Ltd. (NASDAQ:CLBT) Suggests It's 33% UndervaluedMay 4, 2024 | marketbeat.com74,834 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Purchased by Hsbc Holdings PLCHsbc Holdings PLC acquired a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 74,834 shares of the company's stock, valued at approMay 1, 2024 | seekingalpha.comGreenhaven Road Capital - Cellebrite: Own A Growing, Cash Flowing, Below Market Multiple CompanyApril 20, 2024 | msn.comLake Street Initiates Coverage of Cellebrite DI (CLBT) with Buy RecommendationApril 19, 2024 | marketbeat.comLake Street Capital Begins Coverage on Cellebrite DI (NASDAQ:CLBT)Lake Street Capital initiated coverage on shares of Cellebrite DI in a report on Friday. They issued a "buy" rating and a $13.00 price target for the company.April 15, 2024 | marketbeat.comVoss Capital LLC Raises Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)Voss Capital LLC raised its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 207.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,835,000 shares of the company's stock after acqApril 10, 2024 | globenewswire.comCellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024April 4, 2024 | marketbeat.com205,021 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Bought by Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTDKranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investorApril 1, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Short Interest Up 11.5% in MarchCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,620,000 shares, an increase of 11.5% from the February 29th total of 2,350,000 shares. Based on an average daily volume of 978,000 shares, the short-interest ratio is presently 2.7 days. Currently, 4.7% of the company's shares are sold short.April 1, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Price Target Raised to $16.00 at Craig HallumCraig Hallum increased their price target on Cellebrite DI from $14.00 to $16.00 and gave the stock a "buy" rating in a report on Monday.March 28, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Technology Stocks: Verint Systems (VRNT), Cellebrite DI (CLBT)March 28, 2024 | finance.yahoo.comWhat Does Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price Indicate?March 28, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Price Target Raised to $13.50Needham & Company LLC raised their price objective on shares of Cellebrite DI from $13.00 to $13.50 and gave the stock a "buy" rating in a report on Thursday.March 27, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Shares Down 4.6% Cellebrite DI (NASDAQ:CLBT) Stock Price Down 4.6%March 25, 2024 | globenewswire.comCellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market LeadershipMarch 21, 2024 | finance.yahoo.comCellebrite Files its 2023 Annual Report on Form 20-FMarch 21, 2024 | globenewswire.comCellebrite Files its 2023 Annual Report on Form 20-FMarch 18, 2024 | marketbeat.comCellebrite DI Target of Unusually Large Options Trading (NASDAQ:CLBT)Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) was the recipient of unusually large options trading on Monday. Stock traders purchased 5,037 call options on the stock. This represents an increase of approximately 3,604% compared to the typical volume of 136 call options.March 14, 2024 | finance.yahoo.comCellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure PlatformMarch 14, 2024 | globenewswire.comCellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company's Case-to-Closure PlatformMarch 13, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Shares Gap Up to $11.51Cellebrite DI (NASDAQ:CLBT) Shares Gap Up to $11.51March 13, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Given Consensus Rating of "Buy" by AnalystsCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has been given an average rating of "Buy" by the four research firms that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy recommendation. The average 12-month price target among bMarch 13, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Shares Sold by Greenhaven Road Investment Management L.P.Greenhaven Road Investment Management L.P. lessened its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 10.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,172,607 shares of the company's stockMarch 13, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Rating Increased to Outperform at William BlairWilliam Blair raised shares of Cellebrite DI from a "market perform" rating to an "outperform" rating in a report on Wednesday.March 12, 2024 | globenewswire.comUPDATE – Cellebrite Announces 2024 Investor DayMarch 12, 2024 | globenewswire.comCellebrite Announces 2024 Investor DayMarch 7, 2024 | globenewswire.comCellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud SecurityMarch 7, 2024 | globenewswire.comCellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud SecurityMarch 6, 2024 | finanznachrichten.deCellebrite DI Ltd: Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth PhaseMarch 6, 2024 | globenewswire.comHaim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth PhaseMarch 4, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Hits New 12-Month High at $12.61Cellebrite DI (NASDAQ:CLBT) Reaches New 12-Month High at $12.61February 26, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Reaches New 12-Month High at $11.96Cellebrite DI (NASDAQ:CLBT) Hits New 1-Year High at $11.96February 26, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Raises Stock Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 135.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 732,884 shares of the company's stock after buyingFebruary 23, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Shares Bought by Brasada Capital Management LPBrasada Capital Management LP lifted its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 125.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 375,332 shares of the company's stock afterFebruary 22, 2024 | marketbeat.comAcadian Asset Management LLC Has $12.56 Million Stake in Cellebrite DI Ltd. (NASDAQ:CLBT)Acadian Asset Management LLC grew its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 295.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,646,480 shares of the company's stock after acquiring an additional 1,February 21, 2024 | investors.comCheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Bitcoin Miner Aims At BreakoutFebruary 20, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Reaches New 1-Year High at $11.92Cellebrite DI (NASDAQ:CLBT) Reaches New 1-Year High at $11.92February 19, 2024 | msn.comCellebrite DI Ltd. (CLBT) Is Up 20.78% in One Week: What You Should KnowFebruary 18, 2024 | finance.yahoo.comCellebrite DI Ltd. (NASDAQ:CLBT) Just Reported And Analysts Have Been Lifting Their Price TargetsFebruary 16, 2024 | finance.yahoo.comCellebrite DI Ltd. (NASDAQ:CLBT) Q4 2023 Earnings Call TranscriptFebruary 16, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Trading Up 4.9% Following Analyst UpgradeCellebrite DI (NASDAQ:CLBT) Trading 4.9% Higher Following Analyst UpgradeFebruary 16, 2024 | finance.yahoo.comprivate companies who own 48% along with institutions invested in Cellebrite DI Ltd. (NASDAQ:CLBT) saw increase in their holdings value last weekFebruary 16, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Lifted to "Buy" at Bank of AmericaBank of America raised Cellebrite DI from a "neutral" rating to a "buy" rating and upped their price target for the company from $9.00 to $12.00 in a report on Friday.February 15, 2024 | markets.businessinsider.comWilliam Blair Keeps Their Hold Rating on Cellebrite DI (CLBT)February 15, 2024 | finanznachrichten.deCellebrite DI Ltd: Cellebrite Announces Fourth-Quarter 2023 ResultsFebruary 15, 2024 | seekingalpha.comCellebrite DI Ltd. 2023 Q4 - Results - Earnings Call Presentation Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump. Click here to see why it will be ______ _________. CLBT Media Mentions By Week CLBT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLBT News Sentiment▼0.920.47▲Average Business Services News Sentiment CLBT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLBT Articles This Week▼52▲CLBT Articles Average Week Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: N-able News Jamf News Lightspeed Commerce News Marqeta News Instructure News AvePoint News Matterport News Coursera News MeridianLink News Sprinklr News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLBT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward PressBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
